Skip to main content

ACG 2022 Annual Meeting Main banner

Tweets by ACG 2022 Annual Meeting

Browse by Presenter

Browse by Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

F
Faleck, David

Memorial Sloan Kettering Cancer Center
Immune Checkpoint Inhibitor Colitis and Other GI-Related Adverse Events

David Faleck
Falk, Gary

University of Pennsylvania Perelman School of Medicine
Plenary Session 1A - Esophagus
Gary Falk
Fang, John

University of Utah
My Tube is Leaking…Complications and Management of Troublesome Enteral Tubes

John Fang
Fass, Ronnie

The Esophageal and Swallowing Center, MetroHealth Medical System, Case Western Reserve University
14 - Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial

Ronnie Fass
Feagan, Brian

Alimentiv, Inc.; Western University
1 - Benefits of High versus Low Dose Upadacitinib as Maintenance Treatment in Ulcerative Colitis Patients Who Were Responders to 8-week Induction with Upadacitinib: Results From the U-ACHIEVE Phase 3 Maintenance Trial

Brian Feagan
40 - Induction Combination Therapy With Guselkumab and Golimumab Followed by Guselkumab Monotherapy Maintenance: Results of the Phase 2a, Randomized, Double-Blind, Proof-of-Concept VEGA Study

Brian Feagan
Ferrante, Marc

University Hospitals Leuven
39 - Clinical and Endoscopic Improvements With Risankizumab Induction and Maintenance Dosing versus Placebo Are Observed Irrespective of Number of Prior Failed Biologics

Marc Ferrante
Feuerstadt, Paul

Yale University, School of Medicine/PACT Gastroenterology Center
Fecal Transplants for C. difficile in 2022: Are We There Yet?

Paul Feuerstadt
Learning Luncheon 01: What Every Clinician Needs to Know About the Microbiome: Composition, Function and Emerging Live Microbiome Therapeutics

Paul Feuerstadt
Q & A - Symposium 2B

Paul Feuerstadt
Symposium 2B: C. difficile Controversies
Paul Feuerstadt
Fraser, Scott

Fraser Healthcare
Panel Discussion: Disruption or Distortion: Emergent Practices in GI

Scott Fraser
Freeman, Martin

University of Minnesota
Complications of ERCP: How to Identify and Address Them

Martin Freeman
Fritz, Cassandra

Barnes-Jewish Hospital at Washington University in Saint Louis
Allyship for URMs in GI Challenges and Solutions to Satisfy an Unmet Need

Cassandra Fritz
Fukami, Norio

Mayo Clinic Arizona
Hands-on Workshop - ESD with the Experts

Norio Fukami
Hands-on Workshop - ESD with the Experts

Norio Fukami
Furth, Emma

Hospital of the University of Pennsylvania
Understanding Polyps, Tumors, IBD and More: Pathology and Imaging of the Colon and Rectum

Emma Furth